XML 74 R63.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders’ Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 17, 2022
Jan. 20, 2022
Mar. 31, 2022
Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common stock declared (in USD per share) $ 0.45 $ 0.15    
Dividends payable $ 4,900 $ 2,600    
Grants in period (in shares)     22,201 9,454
Stock compensation expense for employee and directors     $ 300 $ 100
Unvested restricted shares (in shares)     138,856 6,296
Unrecognized compensation expense     $ 2,500  
Employee        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock compensation expense for employee and directors     $ 169 $ 62
Employee | Officer        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation, payment award, vesting period (in years)     5 years  
Employee | Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation, payment award, vesting period (in years)     3 years  
Employee | Maximum | Executive Officer        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation, payment award, vesting period (in years)     7 years  
Director        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock compensation expense for employee and directors     $ 108 $ 0
Director | Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation, payment award, vesting period (in years)     1 year  
Director | Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation, payment award, vesting period (in years)     3 years  
Restricted Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Grants in period (in shares)     22,201 9,454
Forfeited in period (in shares)     850 2,722